A Mendelian randomization (MR) study of SMs and breast cancer risk reported a null association with breast cancer [42], while an MR study of SMs in breast cancer survival indicated an inverse association with risk of breast cancer-specific death (in women with estrogen-receptor positive tumors) [43]. This evidence concerns the gene ESR1 and breast cancer.